Details for Patent: 7,709,517
✉ Email this page to a colleague
Which drugs does patent 7,709,517 protect, and when does it expire?
Patent 7,709,517 protects XTANDI and is included in two NDAs.
This patent has one hundred and thirty-seven patent family members in twenty-eight countries.
Summary for Patent: 7,709,517
Title: | Diarylhydantoin compounds |
Abstract: | The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer. |
Inventor(s): | Sawyers; Charles L. (New York, NY), Jung; Michael E. (Los Angeles, CA), Chen; Charlie D. (Los Angeles, CA), Ouk; Samedy (Costa Mesa, CA), Welsbie; Derek (Northridge, CA), Tran; Chris (New York, NY), Wongvipat; John (Nanuet, NY), Yoo; Dongwon (Los Angeles, CA) |
Assignee: | The Regents of the University of California (Oakland, CA) |
Application Number: | 11/433,829 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,709,517 |
Patent Claim Types: see list of patent claims | Compound; Composition; |
Drugs Protected by US Patent 7,709,517
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | XTANDI | enzalutamide | CAPSULE;ORAL | 203415-001 | Aug 31, 2012 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Astellas | XTANDI | enzalutamide | TABLET;ORAL | 213674-001 | Aug 4, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Astellas | XTANDI | enzalutamide | TABLET;ORAL | 213674-002 | Aug 4, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,709,517
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1893196 | ⤷ Sign Up | C300632 | Netherlands | ⤷ Sign Up |
European Patent Office | 1893196 | ⤷ Sign Up | CA 2013 00065 | Denmark | ⤷ Sign Up |
European Patent Office | 1893196 | ⤷ Sign Up | PA2013029 | Lithuania | ⤷ Sign Up |
European Patent Office | 1893196 | ⤷ Sign Up | 1390060-0 | Sweden | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |